Le Lézard
Classified in: Health

Manage My Pain Helping Wean Patients Off Opioids in Clinical Trial Across 5 Hospitals


TORONTO, July 18, 2018 /PRNewswire/ -- A randomized controlled clinical trial focused on weaning patients off opioids has licensed "Manage My Pain", an app-based chronic pain management and monitoring tool.  The 3-year multi-site trial will examine the effectiveness of the Transitional Pain Service Program (TPSP) at 5 Ontario hospitals and integrate "Manage My Pain" alongside a variety of methods to support patients to manage their pain and wean off opioids in the months after major surgery.

After major surgery, patients are at-risk of developing chronic post-surgical pain (CPSP) and using opioids persistently to manage their pain. The Toronto General Hospital created the Transitional Pain Service Program to deliver innovative treatment aimed at reducing the incidence and severity of CPSP, disability, and enabling safe opioid prescribing / weaning after major surgery. It the world's first multi-disciplinary program focused on post-surgical pain management and includes physician-guided opioid and non-opioid pharmacotherapy and tapering, clinical psychology services, pain education, and the Manage My Pain application.

"There is a need to use all the tools we have at our disposal to help patients manage their pain after surgery," says Dr. Hance Clarke, the Principal Investigator of the clinical trial and Medical Director of Pain Services at the University Health Network.  "Manage My Pain is a strong complement to the variety of methods we use for pain management and opioid weaning within the TPSP."

The 3-year project is funded by the Health Services Research Fund of the Ontario Ministry of Health of Long-Term Care. The clinical trial will include pain clinics based out of Toronto General Hospital, Toronto Western Hospital, Hamilton Health Sciences, Rouge Valley Centenary Hospital, and the Thunder Bay Regional Health Sciences Centre.

"The Transitional Pain Service Program is an amazing example of how clinical innovation can help address the opioid crisis," says Tahir Janmohamed, CEO of ManagingLife. "We are proud that Manage My Pain is part of that innovation and we are excited to work with Dr. Clarke and the rest of the study team."

About ManagingLife

ManagingLife is a privately held Corporation based in Toronto, Canada that uses patient engagement and analytics to help chronic pain sufferers and practitioners learn more about their condition and better communicate with each other.  ManagingLife's app-based tool, "Manage My Pain" is used by over 30,000 chronic pain sufferers from over 130 countries to record their pain, function, and medication consumption. ManagingLife works with hospitals, clinical trials, and insurers to help healthcare professionals better measure, monitor, and manage their patients' pain and medications.

About the Health Services Research Fund (HSRF)

Building on the scientific excellence and strategic value provided by Ontario-based researchers, the HSRF funds policy relevant research across the province.  The HSRF is based on the Ministry of Health and Long-Term Care health system research strategy, established in 2008 and updated in 2012.

Media contact:
Michelle Bashir
[email protected] 
416-910-3950

SOURCE ManagingLife


These press releases may also interest you

at 08:53
Carolinas ContinueCARE Hospital at Pineville celebrates its 10th anniversary, as well as 20 total years of providing long-term acute care services to its community. Carolinas ContinueCARE Hospital at Pineville is located in the heart of Charlotte,...

at 08:52
Knowtion Health, a leader in insurance claims resolution and recovery to improve revenue cycle outcomes for hospitals and health systems throughout the United States, announced that Satchel Kiefer has been promoted to Chief Revenue Officer,...

at 08:50
Health Advocate, a leading provider of integrated health advocacy and navigation, well-being, and behavioral health programs, announced it has partnered with Tava Health to expand access to digital teletherapy and enable members to seamlessly connect...

at 08:50
Signet Jewelers, the world's largest retailer of diamond jewelry,...

at 08:45
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, has entered into a licensing agreement with Braingaze Ltd. (Braingaze) and...

at 08:45
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the pricing of its "reasonable best efforts" public offering of 15,197,500 shares of common stock (or...



News published on and distributed by: